MUBUSHAR RAZA: Open Payments
NPI 1588017164 · BRENTWOOD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 22 payments from 12 companies in 2025. Trend: 2023 $1,292 · 2024 $1,720 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $92 |
| TerSera Therapeutics LLC | 3 | $79 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $57 |
| ABBVIE INC. | 3 | $46 |
| SCILEX PHARMACEUTICALS INC. | 2 | $43 |
| Novo Nordisk Inc | 1 | $23 |
| Orexo US, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Intra-Sana Laboratories | 1 | $18 |
Products named: RELISTOR, Prialt, JOURNAVX, ZTLido, QULIPTA, Zubsolv, NURTEC ODT, XTAMPZA.
Industry payments across NY — which companies pay providers there.
